Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

19.85
Delayed Data
As of May 29
 +0.57 / +2.96%
Today’s Change
9.38
Today|||52-Week Range
20.75
+64.87%
Year-to-Date

Today’s Trading

Previous close19.28
Today’s open19.35
Day’s range19.31 - 20.18
Volume1,480,081
Average volume (3 months)1,033,251
Market cap$1.3B
Dividend yield--
Data as of 4:14pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)+10.33%
Earnings growth (this year)+70.26%
Earnings growth (next 5 years)--
Revenue growth (last year)+47.33%
P/E ratioNM
Price/Sales11.91
Price/Book5.24

Competitors

 Today’s
change
Today’s
% change
FMIFoundation Medicine ...+0.51+1.45%
RTRXRetrophin Inc+1.61+5.36%
ADAPAdaptimmune Therapeu...+0.10+0.65%
RLYPRelypsa Inc+0.77+2.14%
Data as of 4:00pm ET, 05/29/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$52.3M
Annual profit (last year)-$98.6M
Net profit margin-188.71%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Craig A. Wheeler
Chief Financial Officer &
Senior Vice President
Richard P. Shea
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers